Dr Reddy's Laboratories Celebrates 25 Years on NYSE with Closing Bell Ceremony

On a momentous occasion, Dr Reddy's Laboratories celebrated its quarter-century of listing on the New York Stock Exchange by participating in the iconic closing bell ceremony. The pharmaceutical company's leadership, including Chairman Satish Reddy, gathered on this prestigious platform to honor 25 years of their presence on the world stage.

Dr Reddy's originally became the first Asian pharmaceutical firm outside Japan to list on the NYSE in April 2001. The silver jubilee event was attended by key members including CEO Erez Israeli and CFO MV Narasimham. In his address, Satish Reddy reaffirmed their dedication to global governance and affordable healthcare, channeling the original vision set by the company's founder, K Anji Reddy. Moving forward, the company remains committed to widening access to innovative medical solutions.

(With inputs from agencies.)